Corcept Therapeutics
CORT
CORT
320 hedge funds and large institutions have $4.09B invested in Corcept Therapeutics in 2024 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 106 increasing their positions, 106 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
13% more funds holding
Funds holding: 284 → 320 (+36)
0% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 106
1.06% less ownership
Funds ownership: 85.7% → 84.64% (-1.1%)
Holders
320
Holding in Top 10
7
Calls
$54.3M
Puts
$33.3M
Top Buyers
| 1 | +$16.1M | |
| 2 | +$15.6M | |
| 3 | +$12.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.56M |
| 5 |
MGP
M&G plc
London,
United Kingdom
|
+$8.63M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$17M | |
| 3 | -$14.3M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$10.1M |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$9.22M |